cro.directory
← Home
Clario logo

Clario

Science-informed endpoint technology and global clinical trial management for every phase of drug development.

Listed on cro.directory

Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade. Headquartered in Multiple (100+ countries).

Phases

Indications / Therapeutic Areas

Services

Modalities

Technical specifications & accreditations

About this organization

Overview

Clario is a leading provider of clinical trial endpoint data solutions serving pharmaceutical, biotech, and CRO customers across every phase of drug development. The company combines science-informed endpoint technology, global scale, and expert clinical trial management services to generate reliable clinical evidence.

Core Capabilities

Endpoint Technologies & Data Solutions:

  • Cardiac safety monitoring and arrhythmia assessment
  • eCOA (electronic Clinical Outcome Assessment) platforms including eCOA Live and eCOA Multimedia
  • Medical imaging with clinical adjudication and AI-powered image redaction
  • Respiratory endpoint solutions
  • Precision motion analysis via the OPAL® System for movement disorders and neuroscience applications
  • Trial enablement solutions including eConsent, source document management, eligibility assessment, and reporting analytics

Clinical Trial Management:

  • Support for site-based, hybrid, and decentralized clinical trials
  • 24/7 customer and patient support with integrated training and instructions
  • Global deployment across over 100 countries with translations in over 100 languages
  • Experience delivering over 30,000 clinical trials

Scientific & Regulatory Expertise:

  • Team of hundreds of clinical trial management experts with therapeutic area and endpoint science specialization
  • Extensive global regulatory experience supporting FDA and EMA submissions
  • Clinical adjudication and statistical analysis capabilities

Scale & Impact

Clario's platform supports approximately 70% of FDA and EMA novel drug approvals over the past decade. The company operates globally with thousands of customer operations professionals and approximately 4,000 employees worldwide.

Locations

  • Global Operations

    Multiple (100+ countries)

Submit a verified review for this organization.

Markdown mirror: /companies/clario.md